Claire M. Fraser

Last updated
Claire M Fraser
Claire M Fraser-Liggett (cropped).jpg
Born1955 (age 67–68)
NationalityAmerican
Alma mater
Awards
Scientific career
Fields
Institutions University of Maryland, Baltimore
Thesis Autoantibodies and monoclonal antibodies to ℓgbℓs-adrenergic receptors : their role in receptor characterization and human physiology (1981)
Website

Claire M. Fraser (born 1955) is an American genome scientist and microbiologist who has worked in microbial genomics and genome medicine. [1] Her research has contributed to the understanding of the diversity and evolution of microbial life. Fraser is the director of the Institute for Genome Sciences at the University of Maryland School of Medicine in Baltimore, MD, where she holds the Dean's Endowed Professorship in the School of Medicine. She has joint faculty appointments at the University of Maryland School of Medicine in the Departments of Medicine and Microbiology/Immunology. In 2019, she began serving a one-year term as President-Elect for the American Association for the Advancement of Science (AAAS), which will be followed by a one-year term as AAAS president starting in February 2020 and a one-year term as chair of the Board of Directors in February 2021. [2]

Contents

Early life

Fraser was raised by a high school principal and an elementary school teacher in Saugus, MA a suburb of Boston, MA. [1] She performed well at school and was always interested in learning. [1] She became interested in science after being taught biology in high school. [1] At Rensselaer Polytechnic Institute (RPI), during her senior year, she performed independent research in a research lab. [1]

Education

Fraser received her B.S. degree in Biology from Rensselaer Polytechnic Institute in 1977 and her Ph.D. degree in Pharmacology at the State University of New York at Buffalo in 1981 with a thesis entitled "Autoantibodies and monoclonal antibodies to ℓgbℓs-adrenergic receptors : their role in receptor characterization and human physiology". [3]

Career

Fraser has authored more than 300 publications with more than 50,000 citations, edited four books, and served on the editorial boards of nine scientific journals. [4] She is included on 23 issued patents and 19 published patents [4]

Genomics

From 1998 to 2007, Fraser was president and director of The Institute for Genomic Research (TIGR) in Rockville, MD, and led the teams that sequenced the genomes of bacterial and parasitic pathogens and the first model plant, Arabidopsis thaliana . [5] [6] [7] [8] In 1995, Fraser was part of the team to first sequence the complete genome of a free-living organism—Haemophilus influenzae—the bacterium that causes lower respiratory tract infections and meningitis in infants and young children. [9] In 2007, Fraser joined the University of Maryland School of Medicine as director of the new Institute for Genome Sciences. [10]

Fraser's work on the 2001 Amerithrax investigation led to the identification of four genetic mutations in the anthrax spores that enabled the FBI to trace the material back to its original source. [8] This effort catalyzed the development of the field of microbial forensics. She is an expert in microbial forensics and the growing concern about dual uses – research that can provide knowledge and technologies that could be misapplied. [11]

Fraser has led NIAID-funded efforts in the genomics of infectious disease, including the current iteration of the Genome Centers for Infectious Disease. [12] Past and current studies funded through these initiatives aim to explore the dynamic interactions between high-priority pathogens, hosts, their microbiota, the immune system, and the environment, with the goal to provide a comprehensive understanding of the determinants of infectious disease with hypothesis-driven research using high-throughput "-omics" technologies. [13] [14] [15] [16] [17] These projects both stimulate and enhance ongoing technology development in technology and data cores. [18] [19] [20]

Fraser's current research is part of the Human Microbiome Project and is focused on how the structure and function of microbial communities in the human gastrointestinal tract change in association with diseases such as obesity and inflammatory bowel disease, and how these communities respond to interventions including oral vaccination and probiotics administration. [21] [22]

Advisory panels and editorial boards

In 2019, Fraser is serving a one-year term as President-Elect for the American Association for the Advancement of Science (AAAS), which will be followed by a one-year term as AAAS president starting in February 2020 and a one-year term as chair of the Board of Directors in February 2021. [2] In accepting the nomination to be a candidate for AAAS President, Fraser expressed a desire to use this position to be an ardent spokesperson for science and to promote application of the scientific method to the solution of our most pressing problems, including climate change, antimicrobial resistance as well as food security, water security, and energy security. [23] She notes that "our ability to respond to these challenges has been hampered to a considerable extent by a lack of adequate funding, a tendency to fund 'safer' research projects, and a relative lack of public trust in science.". [23]

Fraser has been an editor for journals mBio , Journal of Bacteriology , Microbial Genomics (journal) , Molecular Case Studies, and DNA and Cell Biology . [24] [25] [26] [27] [28] Since 2006, Fraser has also served as a member of the Board of Directors of Becton, Dickinson and Company (BD), a Fortune 500 medical technology company. [29]

Awards and nominations

Personal life

Fraser was previously married to Craig Venter. Since 2013, she has been married to Jack Kammer, an author who examines gender issues from a male point of view. [43] Fraser has owned several standard poodles, including Shadow whose genome was sequenced. [44]

Related Research Articles

<span class="mw-page-title-main">Craig Venter</span> American biotechnologist and businessman

John Craig Venter is an American biotechnologist and businessman. He is known for leading one of the first draft sequences of the human genome and assembled the first team to transfect a cell with a synthetic chromosome. Venter founded Celera Genomics, the Institute for Genomic Research (TIGR) and the J. Craig Venter Institute (JCVI). He was the co-founder of Human Longevity Inc. and Synthetic Genomics. He was listed on Time magazine's 2007 and 2008 Time 100 list of the most influential people in the world. In 2010, the British magazine New Statesman listed Craig Venter at 14th in the list of "The World's 50 Most Influential Figures 2010". In 2012, Venter was honored with Dan David Prize for his contribution to genome research. He was elected to the American Philosophical Society in 2013. He is a member of the USA Science and Engineering Festival's advisory board.

<span class="mw-page-title-main">Genomics</span> Discipline in genetics

Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes. A genome is an organism's complete set of DNA, including all of its genes as well as its hierarchical, three-dimensional structural configuration. In contrast to genetics, which refers to the study of individual genes and their roles in inheritance, genomics aims at the collective characterization and quantification of all of an organism's genes, their interrelations and influence on the organism. Genes may direct the production of proteins with the assistance of enzymes and messenger molecules. In turn, proteins make up body structures such as organs and tissues as well as control chemical reactions and carry signals between cells. Genomics also involves the sequencing and analysis of genomes through uses of high throughput DNA sequencing and bioinformatics to assemble and analyze the function and structure of entire genomes. Advances in genomics have triggered a revolution in discovery-based research and systems biology to facilitate understanding of even the most complex biological systems such as the brain.

<span class="mw-page-title-main">Human microbiome</span> Microorganisms in or on human skin and biofluids

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Though micro-animals can also live on the human body, they are typically excluded from this definition. In the context of genomics, the term human microbiome is sometimes used to refer to the collective genomes of resident microorganisms; however, the term human metagenome has the same meaning.

<span class="mw-page-title-main">Comparative genomics</span>

Comparative genomics is a field of biological research in which the genomic features of different organisms are compared. The genomic features may include the DNA sequence, genes, gene order, regulatory sequences, and other genomic structural landmarks. In this branch of genomics, whole or large parts of genomes resulting from genome projects are compared to study basic biological similarities and differences as well as evolutionary relationships between organisms. The major principle of comparative genomics is that common features of two organisms will often be encoded within the DNA that is evolutionarily conserved between them. Therefore, comparative genomic approaches start with making some form of alignment of genome sequences and looking for orthologous sequences in the aligned genomes and checking to what extent those sequences are conserved. Based on these, genome and molecular evolution are inferred and this may in turn be put in the context of, for example, phenotypic evolution or population genetics.

<span class="mw-page-title-main">J. Craig Venter Institute</span> Non-profit genomics research institute

The J. Craig Venter Institute (JCVI) is a non-profit genomics research institute founded by J. Craig Venter, Ph.D. in October 2006. The institute was the result of consolidating four organizations: the Center for the Advancement of Genomics, The Institute for Genomic Research (TIGR), the Institute for Biological Energy Alternatives, and the J. Craig Venter Science Foundation Joint Technology Center. It has facilities in Rockville, Maryland and San Diego, California.

<span class="mw-page-title-main">Influenza Genome Sequencing Project</span>

The Influenza Genome Sequencing Project (IGSP), initiated in early 2004, seeks to investigate influenza evolution by providing a public data set of complete influenza genome sequences from collections of isolates representing diverse species distributions.

<span class="mw-page-title-main">Steven Salzberg</span> American biologist and computer scientist

Steven Lloyd Salzberg is an American computational biologist and computer scientist who is a Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University, where he is also Director of the Center for Computational Biology.

Jeffrey Ivan Gordon is a biologist and the Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis. He is internationally known for his research on gastrointestinal development and how gut microbial communities affect normal intestinal function, shape various aspects of human physiology including our nutritional status, and affect predisposition to diseases. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the Institute of Medicine of the National Academies, and the American Philosophical Society.

<span class="mw-page-title-main">Human Microbiome Project</span> Former research initiative

The Human Microbiome Project (HMP) was a United States National Institutes of Health (NIH) research initiative to improve understanding of the microbiota involved in human health and disease. Launched in 2007, the first phase (HMP1) focused on identifying and characterizing human microbiota. The second phase, known as the Integrative Human Microbiome Project (iHMP) launched in 2014 with the aim of generating resources to characterize the microbiome and elucidating the roles of microbes in health and disease states. The program received $170 million in funding by the NIH Common Fund from 2007 to 2016.

Pathogenomics is a field which uses high-throughput screening technology and bioinformatics to study encoded microbe resistance, as well as virulence factors (VFs), which enable a microorganism to infect a host and possibly cause disease. This includes studying genomes of pathogens which cannot be cultured outside of a host. In the past, researchers and medical professionals found it difficult to study and understand pathogenic traits of infectious organisms. With newer technology, pathogen genomes can be identified and sequenced in a much shorter time and at a lower cost, thus improving the ability to diagnose, treat, and even predict and prevent pathogenic infections and disease. It has also allowed researchers to better understand genome evolution events - gene loss, gain, duplication, rearrangement - and how those events impact pathogen resistance and ability to cause disease. This influx of information has created a need for bioinformatics tools and databases to analyze and make the vast amounts of data accessible to researchers, and it has raised ethical questions about the wisdom of reconstructing previously extinct and deadly pathogens in order to better understand virulence.

Metaproteomics is an umbrella term for experimental approaches to study all proteins in microbial communities and microbiomes from environmental sources. Metaproteomics is used to classify experiments that deal with all proteins identified and quantified from complex microbial communities. Metaproteomics approaches are comparable to gene-centric environmental genomics, or metagenomics.

Biological dark matter is an informal term for unclassified or poorly understood genetic material. This genetic material may refer to genetic material produced by unclassified microorganisms. By extension, biological dark matter may also refer to the un-isolated microorganism whose existence can only be inferred from the genetic material that they produce. Some of the genetic material may not fall under the three existing domains of life: Bacteria, Archaea and Eukaryota; thus, it has been suggested that a possible fourth domain of life may yet be discovered, although other explanations are also probable. Alternatively, the genetic material may refer to non-coding DNA and non-coding RNA produced by known organisms.

<span class="mw-page-title-main">Karen E. Nelson</span> Jamaican-born American microbiologist

Karen Nelson is a Jamaican-born American microbiologist who was formerly president of the J. Craig Venter Institute (JCVI). On July 6, 2021 she joined Thermo Fisher Scientific as Chief Scientific Officer.

<span class="mw-page-title-main">Curtis Huttenhower</span>

Curtis Huttenhower is a Professor of Computational Biology and Bioinformatics in the Department of Biostatistics, School of Public Health, Harvard University.

<span class="mw-page-title-main">Multiomics</span>

Multiomics, multi-omics, integrative omics, "panomics" or "pan-omics" is a biological analysis approach in which the data sets are multiple "omes", such as the genome, proteome, transcriptome, epigenome, metabolome, and microbiome ; in other words, the use of multiple omics technologies to study life in a concerted way. By combining these "omes", scientists can analyze complex biological big data to find novel associations between biological entities, pinpoint relevant biomarkers and build elaborate markers of disease and physiology. In doing so, multiomics integrates diverse omics data to find a coherently matching geno-pheno-envirotype relationship or association. The OmicTools service lists more than 99 softwares related to multiomic data analysis, as well as more than 99 databases on the topic.

Microbiomes of the built environment is a field of inquiry into the communities of microorganisms that live in human constructed environments like houses, cars and water pipes. It is also sometimes referred to as microbiology of the built environment.

<span class="mw-page-title-main">Pharmacomicrobiomics</span>

Pharmacomicrobiomics, proposed by Prof. Marco Candela for the ERC-2009-StG project call, and publicly coined for the first time in 2010 by Rizkallah et al., is defined as the effect of microbiome variations on drug disposition, action, and toxicity. Pharmacomicrobiomics is concerned with the interaction between xenobiotics, or foreign compounds, and the gut microbiome. It is estimated that over 100 trillion prokaryotes representing more than 1000 species reside in the gut. Within the gut, microbes help modulate developmental, immunological and nutrition host functions. The aggregate genome of microbes extends the metabolic capabilities of humans, allowing them to capture nutrients from diverse sources. Namely, through the secretion of enzymes that assist in the metabolism of chemicals foreign to the body, modification of liver and intestinal enzymes, and modulation of the expression of human metabolic genes, microbes can significantly impact the ingestion of xenobiotics.

Owen R. White is a bioinformatician and director of the Institute For Genome Sciences at the University of Maryland School of Medicine. He is known for his work on the bioinformatics tools GLIMMER and MUMmer.

<span class="mw-page-title-main">Microbiome-wide association study</span>

A microbiome-wide association study (MWAS), otherwise known as a metagenome-wide association study (MGWAS), is a statistical methodology used to examine the full metagenome of a defined microbiome in various organisms to determine if some feature of the microbiome is associated with a host trait. MWAS has been adopted by the field of metagenomics from the widely used genome-wide association study (GWAS).

Trevor Lawley FMedSci is a Faculty member and Group Leader in the Host-Microbiota Interactions Lab at the Wellcome Sanger Institute (WSI). He is also co-founder and Chief Scientific Officer of the biotech company Microbiotica.

References

  1. 1 2 3 4 5 Katherine Lee (December 17, 2018). ""Claire M. Fraser Is a Pioneer Who's Just Getting Started"" . Retrieved March 31, 2019.
  2. 1 2 "Microbial Genomics Trailblazer Claire M. Fraser Named AAAS President-Elect".
  3. ↑ "Claire Fraser-Liggett".
  4. 1 2 "Google Scholar".
  5. ↑ Fraser, C. M.; Gocayne, J. D.; et al. (1995). "The minimal gene complement of Mycoplasma genitalium". Science . 270 (5235): 397–403. Bibcode:1995Sci...270..397F. doi:10.1126/science.270.5235.397. PMID   7569993. S2CID   29825758.
  6. ↑ Fraser, C. M.; Casjens, S.; et al. (1997). "Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi". Nature . 390 (6660): 580–586. Bibcode:1997Natur.390..580F. doi: 10.1038/37551 . PMID   9403685. S2CID   4388492.
  7. ↑ Fraser, C. M.; Norris, S. J.; et al. (1998). "Complete genome sequence of Treponema pallidum, the syphilis spirochete". Science . 281 (5375): 375–388. Bibcode:1998Sci...281..375F. doi:10.1126/science.281.5375.375. PMID   9665876.
  8. 1 2 Rasko, D. A.; Worsham, P. L.; Abshire, T. G.; Stanley, S. T.; Bannan, J. D.; Wilson, M. R.; Langham, R. J.; Decker, R. S.; Jiang, L.; Read, T. D.; Phillippy, A. M.; Salzberg, S. L.; Pop, M.; Van Ert, M. N.; Kenefic, L. J.; Keim, P. S.; Fraser-Liggett, C. M.; Ravel, J. (2011). "Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation". Proceedings of the National Academy of Sciences. 108 (12): 5027–5032. Bibcode:2011PNAS..108.5027R. doi: 10.1073/pnas.1016657108 . ISSN   0027-8424. PMC   3064363 . PMID   21383169.
  9. ↑ Fleischmann, R.; Adams, M.; White, O; Clayton, R.; Kirkness, E.; Kerlavage, A.; Bult, C.; Tomb, J.; Dougherty, B.; Merrick, J.; al., e. (1995). "Whole-genome random sequencing and assembly of Haemophilus influenzae Rd". Science. 269 (5223): 496–512. Bibcode:1995Sci...269..496F. doi:10.1126/science.7542800. ISSN   0036-8075. PMID   7542800.
  10. ↑ "University of Maryland School of Medicine". somvweb.som.umaryland.edu. Archived from the original on 2018-03-27. Retrieved 2015-10-28.
  11. ↑ Fraser, Claire M.; Dando, Malcolm R. (2001). "Genomics and future biological weapons: the need for preventive action by the biomedical community". Nature Genetics. 29 (3): 253–256. doi:10.1038/ng763. ISSN   1061-4036. PMID   11687792. S2CID   11211547.
  12. ↑ "Genomic Centers for Infectious Diseases (GCID)" . Retrieved March 30, 2019.
  13. ↑ "Overview, Host, Pathogen and the Microbiome: Determinants of Disease Outcome" . Retrieved March 30, 2019.
  14. ↑ Richter, Taylor K. S.; Hazen, Tracy H.; Lam, Diana; Coles, Christian L.; Seidman, Jessica C.; You, Yaqi; Silbergeld, Ellen K.; Fraser, Claire M.; Rasko, David A.; Bradford, Patricia A. (2018). "Temporal Variability of Escherichia coli Diversity in the Gastrointestinal Tracts of Tanzanian Children with and without Exposure to Antibiotics". mSphere. 3 (6). doi: 10.1128/mSphere.00558-18 . ISSN   2379-5042. PMC   6222053 . PMID   30404930.
  15. ↑ Dara, Antoine; Drábek, Elliott F.; Travassos, Mark A.; Moser, Kara A.; Delcher, Arthur L.; Su, Qi; Hostelley, Timothy; Coulibaly, Drissa; Daou, Modibo; Dembele, Ahmadou; Diarra, Issa; Kone, Abdoulaye K.; Kouriba, Bourema; Laurens, Matthew B.; Niangaly, Amadou; Traore, Karim; Tolo, Youssouf; Fraser, Claire M.; Thera, Mahamadou A.; Djimde, Abdoulaye A.; Doumbo, Ogobara K.; Plowe, Christopher V.; Silva, Joana C. (2017). "New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali". Genome Medicine. 9 (1): 30. doi: 10.1186/s13073-017-0422-4 . ISSN   1756-994X. PMC   5368897 . PMID   28351419.
  16. ↑ Chibucos, Marcus C.; Soliman, Sameh; Gebremariam, Teclegiorgis; Lee, Hongkyu; Daugherty, Sean; Orvis, Joshua; Shetty, Amol C.; Crabtree, Jonathan; Hazen, Tracy H.; Etienne, Kizee A.; Kumari, Priti; O’Connor, Timothy D.; Rasko, David A.; Filler, Scott G.; Fraser, Claire M.; Lockhart, Shawn R.; Skory, Christopher D.; Ibrahim, Ashraf S.; Bruno, Vincent M. (2016). "An integrated genomic and transcriptomic survey of mucormycosis-causing fungi". Nature Communications. 7 (1): 12218. Bibcode:2016NatCo...712218C. doi:10.1038/ncomms12218. ISSN   2041-1723. PMC   4961843 . PMID   27447865.
  17. ↑ Sahl, Jason W.; Sistrunk, Jeticia R.; Fraser, Claire M.; et al. (2015). "Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection". mBio. 6 (3): e00501. doi:10.1128/mBio.00501-15. ISSN   2150-7511. PMC   4462620 . PMID   26060273.
  18. ↑ Chung, Matthew; Teigen, Laura; Liu, Hong; Libro, Silvia; Shetty, Amol; Kumar, Nikhil; Zhao, Xuechu; Bromley, Robin E.; Tallon, Luke J.; Sadzewicz, Lisa; Fraser, Claire M.; Rasko, David A.; Filler, Scott G.; Foster, Jeremy M.; Michalski, Michelle L.; Bruno, Vincent M.; Dunning Hotopp, Julie C. (2018). "Targeted enrichment outperforms other enrichment techniques and enables more multi-species RNA-Seq analyses". Scientific Reports. 8 (1): 13377. Bibcode:2018NatSR...813377C. doi: 10.1038/s41598-018-31420-7 . ISSN   2045-2322. PMC   6127098 . PMID   30190541.
  19. ↑ Robinson, Kelly M.; Hawkins, Aziah S.; Santana-Cruz, Ivette; Adkins, Ricky S.; Shetty, Amol C.; Nagaraj, Sushma; Sadzewicz, Lisa; Tallon, Luke J.; Rasko, David A.; Fraser, Claire M.; Mahurkar, Anup; Silva, Joana C.; Dunning Hotopp, Julie C. (2017). "Aligner optimization increases accuracy and decreases compute times in multi-species sequence data". Microbial Genomics. 3 (9): e000122. doi: 10.1099/mgen.0.000122 . ISSN   2057-5858. PMC   5643015 . PMID   29114401.
  20. ↑ Kumar, Nikhil; Lin, Mingqun; Zhao, Xuechu; Ott, Sandra; Santana-Cruz, Ivette; Daugherty, Sean; Rikihisa, Yasuko; Sadzewicz, Lisa; Tallon, Luke J.; Fraser, Claire M.; Dunning Hotopp, Julie C. (2016). "Efficient Enrichment of Bacterial mRNA from Host-Bacteria Total RNA Samples". Scientific Reports. 6 (1): 34850. Bibcode:2016NatSR...634850K. doi: 10.1038/srep34850 . ISSN   2045-2322. PMC   5054355 . PMID   27713560.
  21. ↑ Zhang, Yan; Brady, Arthur; Jones, Cheron; Song, Yang; Darton, Thomas C.; Jones, Claire; Blohmke, Christoph J.; Pollard, Andrew J.; Magder, Laurence S.; Fasano, Alessio; Sztein, Marcelo B.; Fraser, Claire M.; Dominguez Bello, Maria Gloria (2018). "Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi". mBio. 9 (3). doi: 10.1128/mBio.00686-18 . ISSN   2150-7511. PMC   5941076 . PMID   29739901.
  22. ↑ Eloe-Fadrosh, Emiley A.; Brady, Arthur; Crabtree, Jonathan; Drabek, Elliott F.; Ma, Bing; Mahurkar, Anup; Ravel, Jacques; Haverkamp, Miriam; Fiorino, Anne-Maria; Botelho, Christine; Andreyeva, Irina; Hibberd, Patricia L.; Fraser, Claire M.; McFall-Ngai, Margaret J. (2015). "Functional Dynamics of the Gut Microbiome in Elderly People during Probiotic Consumption". mBio. 6 (2). doi: 10.1128/mBio.00231-15 . ISSN   2150-7511. PMC   4453556 . PMID   25873374.
  23. 1 2 University of Maryland School of Medicine. "UMSOM's Claire Fraser appointed president-elect of AAAS" . Retrieved March 31, 2019.
  24. ↑ "mBio Board of Editors" . Retrieved March 31, 2019.
  25. ↑ "Journal of Bacteriology Masthead" (PDF). January 2005. Retrieved March 31, 2019.
  26. ↑ "Microbial Genomics Editorial Board". Microbiology Society. Retrieved March 31, 2019.
  27. ↑ "About Cold Spring Harbor Molecular Case Studies" . Retrieved March 31, 2019.
  28. ↑ "DNA and Cell Biology About This Journal" . Retrieved March 31, 2019.
  29. ↑ "BD Board of Directors Elects Dr. Claire M. Fraser-Liggett" . Retrieved March 30, 2019.
  30. ↑ "The Ernest Orlando Lawrence Award Laureates" (PDF). US Department of Energy.
  31. ↑ "TIGR's Fraser, Salzberg Honored As AAAS Fellows".
  32. ↑ "TIGR President Wins ASM's Promega Biotechnology Research Award". June 6, 2005.
  33. ↑ "Charles Thom Award and Lecture".
  34. ↑ "Claire Fraser-Liggett to be Inducted in Maryland Women's Hall of Fame". March 19, 2010.
  35. ↑ "Two firms, two university programs win GBC's 2010 Maryland Bioscience Awards".
  36. ↑ "Women in Technology Announces Winners for Its Eleventh Annual Leadership Award" (Press release).
  37. ↑ "Alumni Hall of Fame".
  38. ↑ "IOM Elects 65 New Members, Five Foreign Associates". October 17, 2011.
  39. ↑ "Influential Marylander Honorees". 14 February 2019.
  40. ↑ "2014 Awards".
  41. ↑ "The World's Most Influential Scientific Minds 2014" (PDF).
  42. ↑ "Claire Fraser Named the Inaugural Dean's Endowed Professor". December 9, 2015.
  43. ↑ ""Amazon Jack Kammer"". Amazon. Retrieved March 31, 2019.
  44. ↑ ""Venter, Fraser Use Pet Poodle for Celera/TIGR Dog Genome Project"". May 10, 2002. Retrieved March 31, 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.